Immuno oncology assays include the use of various immunology assays to monitor the interaction between immune cells and cancer cells. The human body's immune system has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also can prevent the recurrence of cancer.
MARKET SCOPE
The "Global Immuno Oncology Assays Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the immuno oncology assays market with detailed market segmentation by technology, indication, application, and geography. The report provides key statistics on the market status of the leading immuno oncology assays market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on technology, the global immuno oncology assays market is segmented into immunoassays, PCR, NGS, flow cytometry, others.
- Based on indication, the global immuno oncology assays market is segmented into colorectal cancer, lung cancer, melanoma, bladder cancer, others
- Based on application, the market is bifurcated into clinical diagnostics, research.
?
MARKET DYNAMICS
Drivers:
- Rising incidence of cancer and growing adoption of targeted therapies
- Increased demand for personalized medicine
- Growing patient preference towards immunotherapies and immunodiagnostics
Restraints:
- Requirement of high capital investments and low cost-benefit ratio
- Unfavorable regulatory and reimbursement scenario
- High cost of immunotherapy
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The immuno oncology assays market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the immuno oncology assays market in these regions.
IMPACT OF COVID-19 ON IMMUNO ONCOLOGY ASSAYS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Numerous patients pretended with COVID-19 were people with malignancies. Investigation in this area is further undertaken to understand better the infection dynamics, which is expected to drive the cancer research field. The shift in demand for research on COVID-19 and oncology has created considerable scope for testing solutions, such as assays and profiling panel testing outcomes. This is further anticipated to drive the demand for immuno-oncology assays and instruments.
MARKET PLAYERS
The report covers key developments in the immuno oncology assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from immuno oncology assays market are anticipated to lucrative growth opportunities in the future with the rising demand for immuno oncology assays in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the immuno oncology assays market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- HTG Molecular Diagnostics, Inc.
- Illumina, Inc.
- Merck KGaA
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Sartorius AG
- NanoString Technologies, Inc.